Related Experiment Videos
[Analysis of drug-induced apoptosis in human leukemic cell line (HL-60)]
Abstract:
Cell death plays an essential role in cell homeostasis and the pathological process in cancer. Apoptosis has been identified by the internucleosomal DNA cleavage which appears to be associated with endonuclease activation. Proteolysis is considered to be an early event in apoptosis. We studied the effects of proteolysis on early apoptotic events, such as chromatin condensation, nuclear breakdown, DNA breakage and sensitivity to denaturation induced by anticancer drugs (camptothecin: CAM, 5-azacytidine: AZA) on HL-60 cells. CAM induced apoptosis on S phase and AZA on G1 phase. The internucleosomal DNA cleavage shown by both the presence of DNA fragments during gel electrophoresis and a large number of in situ DNA strands breaks (revealed in high intensity fluorescence FITC of cells in the TdT reaction) was prevented by the protease inhibitor, TPCK (N-tosyl-L-phenylalanine chlorometyl-ketone), as well as by an inhibitor of the apoptosis-associated endonuclease, ZnSO4. The protective effects were observed under conditions in which apoptosis was induced by agents with a different mechanism of action, such as the DNA damaging drug. CAM (topo-isomerase inhibitor), and an RNA antimetabolite, AZA. The protease inhibitor inhibits early events of apoptosis such as chromatin condensation, nuclear breakdown, DNA breakage and sensitivity to denaturation, which have different structures and a different mechanism of interaction with drugs. The results suggest that control of protease inhibitor may be a useful strategy to treat cancers.
Insights
Protease inhibitors block early apoptosis events like DNA fragmentation, suggesting they may be effective in cancer treatment. This research highlights proteolysis
Area of Science:
- Cell biology
- Biochemistry
- Molecular oncology
Context:
- Apoptosis, a programmed cell death, is crucial for homeostasis and cancer pathology.
- Internucleosomal DNA cleavage, mediated by endonuclease activation, characterizes apoptosis.
- Proteolysis is recognized as an early event in the apoptotic cascade.
Purpose:
- To investigate the impact of proteolysis on early apoptotic events.
- To examine the effects of protease inhibitors on drug-induced apoptosis in HL-60 cells.
- To assess the role of proteolysis in chromatin condensation, nuclear breakdown, and DNA fragmentation.
Summary:
- Protease inhibitors, such as TPCK, prevented internucleosomal DNA cleavage and other early apoptotic events induced by camptothecin (CAM) and 5-azacytidine (AZA) in HL-60 cells.
- These protective effects were observed despite the different mechanisms of action of CAM (topoisomerase inhibitor) and AZA (RNA antimetabolite).
- Inhibiting proteases effectively blocked chromatin condensation, nuclear breakdown, and DNA fragmentation, crucial early steps in apoptosis.
Impact:
- The findings suggest that targeting proteases could be a viable therapeutic strategy for cancer treatment.
- Understanding the role of proteolysis in apoptosis provides insights into novel anti-cancer drug development.
- This study underscores the potential of protease inhibitors in managing cancers by modulating programmed cell death pathways.